טוען...
Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease
Chronic lung diseases (CLDs), including chronic obstructive pulmonary disease (COPD), are the second leading cause of death worldwide. The first report of database-driven drug discovery in carefully phenotyped COPD specimens has now been published in Genome Medicine, combining gene expression data i...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3580440/ https://ncbi.nlm.nih.gov/pubmed/22999295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm371 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|